Literature DB >> 2033389

Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus.

C Bourgeois1, C Corvaisier, J B Bour, E Kohli, P Pothier.   

Abstract

Chemical and enzymic cleavages of the F1 subunit of the fusion (F) protein of respiratory syncytial (RS) virus showed that the sequence 184-Gly to 314-Trp reacted with neutralizing monoclonal antibodies (MAbs). Twelve synthetic peptides covering a part of this sequence were analysed for their immunoreactivity with neutralizing MAbs and anti-RS virus rabbit serum. Two sequential antigenic domains corresponding to amino acids 200 to 225 and 255 to 278 were defined with anti-RS virus rabbit serum. The peptides 205-225 and 259-278, belonging to these antigenic domains, inhibited binding to the F protein and the neutralizing activity of the anti-RS virus rabbit serum. One MAb (RS-348) reacted with peptides containing amino acids 200 to 225. Moreover, the peptide 205-225 induced an anti-peptide rabbit serum neutralizing RS virus in vitro. These results indicate that the sequence from residues 200 to 225 was present in one of the immunodominant sites of the F protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2033389     DOI: 10.1099/0022-1317-72-5-1051

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.

Authors:  Margarita Magro; David Andreu; Paulino Gómez-Puertas; José A Melero; Concepción Palomo
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Antigenic structure of human respiratory syncytial virus fusion glycoprotein.

Authors:  J A López; R Bustos; C Orvell; M Berois; J Arbiza; B García-Barreno; J A Melero
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

3.  A peptide mimic of a protective epitope of respiratory syncytial virus selected from a combinatorial library induces virus-neutralizing antibodies and reduces viral load in vivo.

Authors:  D Chargelegue; O E Obeid; S C Hsu; M D Shaw; A N Denbury; G Taylor; M W Steward
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

4.  Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines.

Authors:  H Sakurai; R A Williamson; J E Crowe; J A Beeler; P Poignard; R B Bastidas; R M Chanock; D R Burton
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  Prophylactic administration of a complementarity-determining region derived from a neutralizing monoclonal antibody is effective against respiratory syncytial virus infection in BALB/c mice.

Authors:  C Bourgeois; J B Bour; L S Aho; P Pothier
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6. 

Authors:  François Freymuth; Geneviève Eugène; Jacques Brouard; Astrid Vabret; Joëlle Petitjean; Françoise Bonnin
Journal:  Ann Inst Pasteur Actual       Date:  2000-04-05

7.  Antigenic analysis of the F protein of the bovine respiratory syncytial virus: identification of two distinct antigenic sites involved in fusion inhibition.

Authors:  J P Matheise; K Walravens; A Collard; P Coppe; J J Letesson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells.

Authors:  Pablo A González; Carolina E Prado; Eduardo D Leiva; Leandro J Carreño; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-25       Impact factor: 11.205

9.  Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro.

Authors:  C Bourgeois; J B Bour; K Lidholt; C Gauthray; P Pothier
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.

Authors:  Roberto S Gómez; Bruno A Ramirez; Pablo F Céspedes; Kelly M Cautivo; Sebastián A Riquelme; Carolina E Prado; Pablo A González; Alexis M Kalergis
Journal:  Immunology       Date:  2015-11-06       Impact factor: 7.397

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.